By comparison, transvenous leads had consistently lower pacing thresholds for both atrial (0.6 vs 1.0µJ; p<0.001) and ventricular (0.8 vs 1.0 µJ, p<0.001) leads than the epicardial counterparts.

Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...

(A full list of lot numbers is on FDA's website.) The 6416 temporary transvenous pacing lead is meant for intracardiac pacing and/or EGM recording for up to seven days. The disposable system includes ...

Cardiac Pacing Leads Market Size By Product Type (Unipolar, Bipolar, and Others), By Technology (Transcutaneous Pacing, Transvenous Pacing, and Epicardial Pacing), By End User (Catheterization ...